Skip to main content
. 2019 Sep 30;14(3):778–784. doi: 10.1007/s12105-019-01083-5

Table 1.

Morphology and molecular findings in overlapping thyroid lesions

Thyroid tumor Morphology IHC Genetic alterations
HTT Nests and cords of cells showing oval-spindle nuclei with nuclear pseudoinclusions and abundant intratrabecular hyaline material KI67/ MIB-1 [cell membrane positivity] Thyroglobulin

PAX8/GLIS1

PAX8/GLIS3

Wild type BRAF and RAS

PTC Papillary and follicular structures with nuclei having irregular border, grooves and pseudoinclusions HBME-1, Galectin-3 and CK19 BRAF V600E mutation
NIFTP Encapsulated tumor made of follicular structures (with no papillae) and more or less prominent nuclear irregularities and pseudoinclusions (as for PTC) Thyroglobulin and PAX8

RAS mutations

THADA fusion

PAX8/PPARγ

BRAF K601E mutation

[Wild type BRAF V600E]

MTC Spindle or plasmacytoid cells with round oval eccentric nuclei containing salt and pepper chromatin in a more or less abundant amorphous stroma (amyloid-rich)

Calcitonin

CEA

Different alterations according to sporadic or familial MTC involving RET gene
Paraganglioma Circumscribed tumor with nesting (zell ballen) or trabecular architecture made of roundish or spindle cells with minimal atypia Neuroendocrine markers and S100 SDHA (or B or C or D) germline mutations
FA Encapsulated tumor made of follicular structures with round homogeneous nuclei Thyroglobulin RAS mutation

HTT hyalinizing trabecular tumor, PTC papillary thyroid carcinoma, NIFTP non-invasive follicular thyroid neoplasm with papillary-like nuclear features, MTC medullary thyroid carcinoma, FA follicular adenoma, IHC immunohistochemistry